Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of crohn's disease

Gastroenterology

Volumn 146, Issue 1, 2014, Pages 200-209

  Vandussen, Kelli L ^a   Liu, Ta Chiang ^a   Li, Dalin ^b   Towfic, Fadi ^c   Modiano, Nir ^b   Winter, Rachel ^b   Haritunians, Talin ^b   Taylor, Kent D ^b   Dhall, Deepti ^b   Targan, Stephan R ^b   Xavier, Ramnik J ^c   McGovern, Dermot P B ^b   Stappenbeck, Thaddeus S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diagnosis; Inflammatory Bowel Disease; Pathogenesis; Prognostic Factor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; LYSOZYME;

ALLELE; ARTICLE; ASSOCIATION; CONTROLLED STUDY; CROHN DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRANULOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE GENE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; PANETH CELL; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SECRETORY GRANULE; STAINING;

EID: 84890735514     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.09.048     Document Type: Article

References (41)

1. J. Burisch, and P. Munkholm Inflammatory bowel disease epidemiology Curr Opin Gastroenterol 29 2013 357 362
2. N.A. Molodecky, I.S. Soon, and D.M. Rabi Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54 e42 quiz e30
3. H.W. Virgin, and J.A. Todd Metagenomics and personalized medicine Cell 147 2011 44 56
4. T.S. Stappenbeck Paneth cell development, differentiation, and function: new molecular cues Gastroenterology 137 2009 30 33
5. N.H. Salzman, D. Ghosh, and K.M. Huttner Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin Nature 422 2003 522 526
6. N.H. Salzman, K. Hung, and D. Haribhai Enteric defensins are essential regulators of intestinal microbial ecology Nat Immunol 11 2010 76 83
7. A.J. Ouellette Paneth cells and innate mucosal immunity Curr Opin Gastroenterol 26 2010 547 553
8. K. Cadwell, J.Y. Liu, and S.L. Brown A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells Nature 456 2008 259 263
9. K. Cadwell, K.K. Patel, and N.S. Maloney Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell 141 2010 1135 1145
10. L. Jostins, S. Ripke, and R.K. Weersma Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
11. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
12. J.P. Hugot, M. Chamaillard, and H. Zouali Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
13. Y. Ogura, D.K. Bonen, and N. Inohara A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606
14. J. Wehkamp, J. Harder, and M. Weichenthal NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression Gut 53 2004 1658 1664
15. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
16. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
17. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657
18. J. Wehkamp, K. Fellermann, and K.R. Herrlinger Mechanisms of disease: defensins in gastrointestinal diseases Nat Clin Pract Gastroenterol Hepatol 2 2005 406 415
19. J. Wehkamp, and E.F. Stange Paneth's disease J Crohns Colitis 4 2010 523 531
20. A. Franke, D.P. McGovern, and J.C. Barrett Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat Genet 42 2010 1118 1125
21. M.A. Rivas, M. Beaudoin, and A. Gardet Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease Nat Genet 43 2011 1066 1073
22. N. Gehlenborg, and B. Wong Heat maps Nat Methods 9 2012 213
23. S. Ramaswamy, P. Tamayo, and R. Rifkin Multiclass cancer diagnosis using tumor gene expression signatures Proc Natl Acad Sci U S A 98 2001 15149 15154
24. D.K. Bonen, Y. Ogura, and D.L. Nicolae Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan Gastroenterology 124 2003 140 146
25. M. Chamaillard, D. Philpott, and S.E. Girardin Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases Proc Natl Acad Sci U S A 100 2003 3455 3460
26. N. Inohara, Y. Ogura, and A. Fontalba Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease J Biol Chem 278 2003 5509 5512
27. J. Li, T. Moran, and E. Swanson Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations Hum Mol Genet 13 2004 1715 1725
28. D. Heresbach, J.L. Alexandre, and B. Branger Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease Gut 54 2005 215 222
29. M. Pierik, G. De Hertogh, and S. Vermeire Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease Gut 54 2005 223 227
30. R. Shaoul, A. Karban, and B. Weiss NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease Inflamm Bowel Dis 10 2004 709 714
31. R. Cooney, J. Baker, and O. Brain NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation Nat Med 16 2010 90 97
32. C.R. Homer, A.L. Richmond, and N.A. Rebert ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis Gastroenterology 139 2010 1630 1641 1641, e1-2
33. L.H. Travassos, L.A. Carneiro, and M. Ramjeet Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry Nat Immunol 11 2010 55 62
34. G.Y. Melmed, and S.R. Targan Future biologic targets for IBD: potentials and pitfalls Nat Rev Gastroenterol Hepatol 7 2010 110 117
35. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
36. T.J. Chambers, and B.C. Morson The granuloma in Crohn's disease Gut 20 1979 269 274
37. D.M. Wolfson, D.B. Sachar, and A. Cohen Granulomas do not affect postoperative recurrence rates in Crohn's disease Gastroenterology 83 1982 405 409
38. C.A. Rubio, A. Orrego, and G. Nesi Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis J Clin Pathol 60 2007 1268 1272
39. F. Cervantes, and M. Mauro Practical management of patients with chronic myeloid leukemia Cancer 117 2011 4343 4354
40. I. Colmegna, B.R. Ohata, and H.A. Menard Current understanding of rheumatoid arthritis therapy Clin Pharmacol Ther 91 2012 607 620
41. M. Dall'era, and E.F. Chakravarty Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies Curr Rheumatol Rep 13 2011 308 316